On Tuesday, Valeant Pharmaceuticals Intl Inc (NYSE:VRX), with shares surged 9.38% is now trading at $16.80. The Stock is active as 15.41M shares changed hands versus its average volume of 14.60M shares.
During the current trading session, the company’s minimum price was $16.45, while it touched its highest price for the day at $17.55. VRX’s beta value stands at -0.13 points. The 52-week range for the stock is $ 13.00 and $ 101.40. The company has a total market capitalization of $5.75 Billion and its total outstanding shares are 341.19 million.
Electronic health records (EHR) dominated the smart healthcare market by accounting for the largest market share. The analysts forecast global smart healthcare market to grow at a CAGR of 24.55% during the period 2016-2020.
The global smart healthcare market analyst says the latest trend gaining momentum in the market is involvement of big data analytics in healthcare. Big data analytics has played a major role in increasing the penetration of smart healthcare products in the market. Big data analytics is being predominantly used in the healthcare sector to understand patient insights. One of the major drivers of smart healthcare market is increased demand for remote monitoring of health conditions of aging population. Higher life anticipation has led to a major increase in the aging population and several chronic diseases, particularly in North America and Western Europe. The rise in chronic diseases, such as diabetes, cancer, arthritis, obesity, asthma, and heart diseases, among the aging population has driven the adoption of smart healthcare products.
For investors focus on the performance of the stocks so the VRX showed weekly ahead performance of 5.72% which was maintained for the month at 1.79%. Correspondingly the negative performance for the quarter was remained -33.72% and if took notice on yearly performance that was -83.14% whereas the year to date performance halted at 5.72%.